alexa A Developing Registry Of Cardiac Clinical Findings (ECG And Holter-monitor Parameters) In Earlyphase Pharmaceutical Trials | 16619
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th International Conference on Clinical & Experimental Cardiology

Joseph Kitzmiller, Marjorie Neidecker, Eduard Mikulik and Glen Apseloff
Posters: J Clin Exp Cardiolog
DOI: 10.4172/2155-9880.S1.020
Abstract
Cardiotoxicty remains a paramount concern in drug development. The FDA mandates significant preclinical analyses of emerging pharmaceuticals, and findings from in vitro and animal models provide guidance regarding the necessary level of cardiotoxity monitoring during the early clinical phases of drug development. Assessments of cardiotoxicity can include serial electrocardiograms (ECGs), Holter-monitoring, telemetry, plasma or serum biomarker tests, or even advanced structural and functional imaging modalities. Thorough QTc studies may also be undertaken to examine the risk for arrhythmias. However, for presumed low-risk compounds, cardiac monitoring may be minimal. Our recently established registry (n~1,000) of study participants in early-phase clinical trials includes demographic information and ECG data (heart rate, intervals, segments, and overall interpretation) for all registrants and the Holter-report findings (numbers of pauses, accelerations, and decelerations in a 24-hour period and an overall interpretation) for nearly half of the registrants. Participants are considered normal healthy after evaluation of clinical laboratory tests, physical examination, and medical and medication histories. Standard statistical analyses of the ECG and Holter-reports of the individuals in our registry of normal healthy participants have been computed. These will be compared historically established normal ECG parameters. ECG parameters and findings will also be compared between individuals with normal and abnormal Holter-reports
Biography
Joseph Kitzmiller, M.D., Ph.D., F.C.P. is a Translational Scholar with the National Institutes of Health and a faculty member in the Colleges of Medicine and Engineering at the Ohio State University (OSU). He is an Associate Director of the OSU?s Center for Pharmacogenomics and Director of their Clinical Pharmacology Fellowship training program. He is a Clinical Supervisor and Consultant for Ohio Clinical Trials and a physician with the Ohio Association of Free Clinics. His completed his Ph.D. in Biomedical Engineering and received postdoctoral training in both Internal Medicine and Clinical Pharmacology. A Board-Certified Clinical Pharmacologist with the American Board of Clinical Pharmacology and a Certified Physician Investigator with the Association of Pharmaceutical Physician Investigators (APPI), he has focused his primary research efforts on investigating genetic influences on cardiovascular disease and pharmacotherapies. He also supervises implements early- and mid-phase drug-development research, with a special interest in cardiotoxicity
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7